Dermatophytes growth curve and in vitro susceptibility test: A broth micro-titration method

Medical Mycology

Volumn 43, Issue 4, 2005, Pages 319-325

  Alió S , Alessandra B ^a   Mendoza, M ^a   Zambrano, E A ^a   Diaz E ^a   Cavallera, E ^a  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

Author keywords

Antifungal susceptibility; Growth curve; Minimum fungicidal concentration; Minimum inhibitory concentration

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOMASS; CONTROLLED STUDY; DERMATOPHYTE; DRY WEIGHT; EPIDERMOPHYTON FLOCCOSUM; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; IN VITRO STUDY; MICROSPORUM CANIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; DRUG RESISTANCE, FUNGAL; EPIDERMOPHYTON; MICROBIAL SENSITIVITY TESTS; MICROSPORUM; TRICHOPHYTON;

ARTHRODERMA BENHAMIAE; ARTHRODERMATACEAE; EPIDERMOPHYTON FLOCCOSUM; FUNGI; MICROSPORUM CANIS; TRICHOPHYTON RUBRUM;

EID: 22744433227     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/13693780500092947     Document Type: Article

References (31)

1. National Casuistic of Superficial and Deep Mycoses during 1999-2000. Presented at the Annual Reunion of Mycology Groups, 5 November 2000, Maracaibo, Venezuela.
2. Kobayaschi G, Spitzer ED. Testing of organism for susceptibility to triazoles. Is it Justified? Eur J Clin Microbiol Infect Dis 1999; 8: 387-389.
3. A'Georgii A, Korting HC. Antifungal susceptibility testing with dermatophytes. Mycoses 1991; 34: 193-199.
4. Cermeño JR, Torres JM, V JR. Estudio de sensibilidad in vitro a los antifúngicos de hongos dematiáceos productores de micetomas, feohifomicosis y cromomicosis. [Chromomicosis, Phaeohyphomycosis and Mycetoma Dematiaceous fungi antifungal in vitro susceptibility test.] PhD. thesis. Barcelona, Spain: Departamento de Pediatría, Obstetricia y Ginecología y Medicina Preventiva, Universidad Autónoma de Barcelona, 1997.
5. Meinhof W. Kinetics and spectrum of activity of oral antifungals: the therapeutic implications. J Am Acad Dermatol 1993; 29: S37-S41.
6. Boudghere-Stambouli O, Merad-Boudia A. Antifungal agents in dermatophytic disease: failure of griseofulvin, ketokonazol and itraconazol drug resistance dermatomycoses. Bull Soc Pathol Exot 1990; 83: 170-176.
7. Norris HA, Elewski BE, Ghannoum MA. Optimal growth conditions for the determination of the anti-fungal susceptibility of three species of dermatophytes with the use of a microdilution method. J Am Acad Dermatol 1999; 40: S9-S13.
8. Espinel-Ingroff A, Dawson K, Pfaller M, et al. Comparative and collaborative evaluation of standardization antifungal susceptibility testing for filamentous fungi. Antimicrob Agents Chemother 1995; 39: 314-319.
9. Espinel-Ingroff A, Bartlett M, Bowden R, et al. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microb 1997; 35: 139-143.
10. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed Standard. NCCLS document M38-P, vol. 18, No. 13. NCCLS, 1998.
11. Pujol L, Aguilar C, Fernández Ballart J, Guarro J. Comparison of minimum fungicidal concentration of amphotericin B determined in filamentous fungi by macrodilution and microdilution methods. Med Mycol 2000; 38: 23-26.
12. Gehrt A, Peter J, Pizzo P, Walsh T. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J Clin Microb 1995; 33: 1302-1307.
13. Rex J, Pfaller M, Galgiani J, et al. Development of interpretative breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro -in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997; 24: 235-247.
14. Jessup CJ, Ryder NS, Ghannoum MA. An evaluation of the in vitro activity of terbinafine. Med Mycol 2000; 38: 155-159.
15. Pirt SJ. Parameter of growth and analysis of growth rate. In: Pirt SJ (ed.). Principles Microbes and Cell Cultivation. New York: John Wiley & Jones, 1975: 4-14.
16. Cermeño JR, Torres Rodríguez JM. Método espectrofotométrico en la preparación del inóculo de hongos dematiáceos. [Spectrophometric method for preparing the inocula of dematiaceous fungi.]. Rev Iberoam Micol 1998; 15: 155-157.
17. Fukuda T, Naka W, Tajima S, Nishikawa T. Neutral red assay in minimum fungicidal concentrations of antifungal agents. J Med Vet Mycol 1996; 34: 353-356.
18. Jessup CJ, Warner J, Isham N, Hasan I, Ghannoum MA. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000; 38: 341-344.
19. Guidry DJ, Findlay M. Rapid quantitative method for measuring the sensitivity of Blastomyces dermatitidis to fungistatic agents. J Bacteriol 1963; 85: 504-508.
20. Bahmer FA, Lorenz E. Evaluation of the growth dynamics of Trichophyton rubrum cultures by morphometry and non-linear curve fitting analysis. Mycoses 2000; 43: 25-28.
21. Jones HE. Problems of resistant dermatophytes. J Am Acad Dermatol 1990; 23(4 Pt 2): 779-781.
22. Granade TC, Hehmann M F, Artis W. Monitoring of filamentous fungal growth by in situ microspectrophotometry, fragmented mycelium absorbance, density, and 14C incorporation: Alternatives to mycelial dry weight. Appl Environ Microbiol 1985; 49: 101-108.
23. Nenoff P, Wolf T, Uwe-Frithjof H. Antifungal susceptibility testing of dermatophytes. Resumen 234. Programa y Resúmenes del 14th Congress Societas Internationalis Mycologiae Humanae et Animalis, 8-13 May 2000, Buenos Aires, Argentina.
24. Colin L, Schlup N, Couprie B, Delarbe H, Mallié M. In vitro antifungal susceptibility testing of dermatophytes. Resumen 478. Programa y Resúmenes del 14th Congress of Societas Internationalis Mycoloagiae Humanae et Animalis, 8-13 May 2000, Buenos Aires, Argentina.
25. Faergemann J. Pharmacokinetics of fluconazole in skin and nails. J Am Acad Dermatol 1999; 40: S14-S20.
26. Goh C, Tay Y, Ali K, Koh M, Seow C. In vitro evaluation of griseofulvin, ketoconazoles and itraconazoles against various dermatophytes in Singapore. Int J Dermatol 1994; 33: 733-737.
27. Espinel-Ingroff A. Clinical utility of in vitro antifungal susceptibility testing. Rev Esp Quimioter 2000; 13: 161-166.
28. Butty P, Lebecq JC, Mallié M, Bastide JM. Evaluation of the susceptibility of dermatophytes to antifungal drugs: a new technique. J Med Vet Mycol 1995; 33: 403-409.
29. Bradley MC, Leidich S, Isham N, et al. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail. Mycoses 1999; 42(Suppl. 2): 105-110.
30. Aly R. Ecology and epidemiology of dermatophytes infection. J Am Acad Dermatol 1994; 31(3 Pt 2): S21-S25.
31. Evans EG. The rationale for combination therapy. Br J Dermatol 2001; 145(Suppl. 60): 9-13.